{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1164.24","meta":{"versionId":"4","lastUpdated":"2017-06-21T01:00:04.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"LUGPA Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-06-21"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.24","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1164.24"}],"version":"20170621","name":"CreatinineClearanceForUrologyCare","title":"Creatinine clearance for urology care","status":"active","experimental":false,"date":"2017-06-21T01:00:04-04:00","publisher":"LUGPA Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values focuses on creatinine clearance as ordered prior to and during administration of bisphosphonates for urology care.),(Data Element Scope: The intent of this data element is to identify creatine clearance as necessary for evaluation prior to and during bisphosphonate therapy in urology care.),(Inclusion Criteria: Serum creatinine clearance),(Exclusion Criteria: None)","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"LP29651-4","display":"Creatinine clearance"}]}]},"expansion":{"identifier":"urn:uuid:dacafe91-96e7-49a6-a9b4-702701240b46","timestamp":"2023-12-10T22:31:03-05:00","total":1,"contains":[{"system":"http://loinc.org","version":"2.76","code":"LP29651-4","display":"Creatinine clearance"}]}}